Nystatin + Thiostrepton + Triamcinolone Acetonide: adverse event reports that FDA received
Combination of 3 active ingredients
The Green Book lists no brand name for exactly these active ingredients.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFrom February 2013 to June 2026, FDA received 95 adverse event reports that name this drug. Its active ingredients are nystatin, thiostrepton and triamcinolone acetonide. Of the 95 reports, 81 (85.3%) are about dogs. 10 reports are about cats (10.5%).
In January to March 2026, FDA received 4 reports that name this drug. The signs that appear in the largest number of the 95 reports are "Deafness" and "Lethargy". A report is not proof that a drug caused a sign.
Fewer than 20 reports named this drug in the 12 months before June 2026, so this page gives no change. Reports about dogs are 85.3% of the reports that name this drug, and 72.6% of all reports.
Search engines list a drug page with 500 reports or more in all years. The page also needs 30 reports or more in the 12 months to June 2026. This page is under one of these numbers. The site keeps the page and keeps it out of search engines.
Since the last update of the FDA data
The latest update of the FDA data, recorded on , changed no count of this page.
January to March 2026 is the latest closed quarter in the data. In that quarter FDA received 4 reports that name nystatin + thiostrepton + triamcinolone acetonide: 4 dog, 0 cat, 0 horse, 0 other or not given.
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 95 reports that list the sign. One report can list more than one sign.
The sign that is in the largest number of the reports comes first.
- Deafness28.4%27 reports
- Lethargy[unusually tired or inactive]11.6%11 reports
- Diarrhoea[diarrhea]10.5%10 reports
- Vomiting10.5%10 reports
- Loss of hearing8.4%8 reports
- Lack of efficacy - NOS[the product did not have the expected effect]7.4%7 reports
- Weight loss7.4%7 reports
- Ear discharge6.3%6 reports
- High sodium-potassium ratio (Na:K ratio)6.3%6 reports
- Not eating6.3%6 reports
- Partial deafness6.3%6 reports
- Shaking6.3%6 reports
- Accidental exposure[exposure that was not intended]5.3%5 reports
- Anxiety5.3%5 reports
Show the next 16 signs
- Decreased appetite5.3%5 reports
- Dehydration5.3%5 reports
- Polyuria[passing more urine than usual]5.3%5 reports
- Appetite disorder NOS[NOS: not otherwise specified]4.2%4 reports
- Distension of abdomen4.2%4 reports
- Hair loss NOS[NOS: not otherwise specified]4.2%4 reports
- Hair shedding4.2%4 reports
- Skin lesion NOS[NOS: not otherwise specified]4.2%4 reports
- Application site reddening[reddening where the product was applied]3.2%3 reports
- Arthritis3.2%3 reports
- Death by euthanasia[the animal was euthanized]3.2%3 reports
- Decreased haematocrit3.2%3 reports
- Discomfort NOS[NOS: not otherwise specified]3.2%3 reports
- Dysorexia3.2%3 reports
- Elevated globulins3.2%3 reports
- Elevated serum alkaline phosphatase (ALP)[a liver and bone enzyme above the normal range]3.2%3 reports
The list shows 30 of 283 coded signs. A report is not proof that a drug caused a sign. Download all signs (CSV)
Reports by species
The share is of all 95 reports that name nystatin + thiostrepton + triamcinolone acetonide. The other reports give a different species or no species.
Reports for each month, Jul 2021 to Jun 2026
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 8 | 0 | 0 | 0 | 8 |
| 2025 | 12 | 2 | 0 | 0 | 14 |
| 2024 | 5 | 0 | 0 | 0 | 5 |
| 2023 | 2 | 0 | 0 | 0 | 2 |
| 2022 | 2 | 1 | 0 | 0 | 3 |
| 2020 | 9 | 1 | 0 | 0 | 10 |
| 2019 | 9 | 1 | 0 | 0 | 10 |
| 2018 | 11 | 3 | 0 | 0 | 14 |
| 2017 | 10 | 1 | 0 | 0 | 11 |
| 2016 | 7 | 1 | 0 | 2 | 10 |
| 2015 | 4 | 0 | 0 | 2 | 6 |
| 2014 | 1 | 0 | 0 | 0 | 1 |
| 2013 | 1 | 0 | 0 | 0 | 1 |
2026 has the reports that FDA received through Jun 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal26.3%25
- Recovered with Sequela[recovered, with a lasting effect]27.4%26
- Ongoing5.3%5
- Died1.1%1
- Euthanized3.2%3
- Outcome Unknown32.6%31
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 95 reports that name nystatin + thiostrepton + triamcinolone acetonide.
A report about more than one animal can have more than one outcome.
Kind of report
- Safety issue86.3%82
- Lack of expected effectiveness4.2%4
- Both safety and lack of expected effectiveness4.2%4
- Manufacturing or product defect5.3%5
- Other0%0
36 reports say if the event was serious. 75% of them have the serious flag. The person who sends the report sets the flag.
Show age, weight, breed and route
Age of the animal
- Under 1 year2.1%2
- 1 to 3 years11.6%11
- 4 to 7 years18.9%18
- 8 to 11 years31.6%30
- 12 years and over28.4%27
- Age not given7.4%7
Weight of the animal
- Under 5 kg (11 lb)17.9%17
- 5 to 9.9 kg (11 to 22 lb)21.1%20
- 10 to 24.9 kg (22 to 55 lb)23.2%22
- 25 to 44.9 kg (55 to 99 lb)24.2%23
- 45 kg and over (99 lb and over)4.2%4
- Weight not given9.5%9
Breed, where the report gives one breed
- Domestic Shorthair9.5%9
- Chihuahua5.3%5
- Boxer3.2%3
- French Bulldog3.2%3
- Pug3.2%3
- Labrador Retriever3.2%3
- German Shepherd Dog3.2%3
- Shih Tzu3.2%3
A breed with many animals has many reports.
Route in the report
- Auricular (Otic)60%57
- Topical23.2%22
- Oral4.2%4
- Ophthalmic1.1%1
Each bar is on a scale of 0 to 100%.
Approved animal drugs with these active ingredients (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
No approved product has exactly this set of active ingredients. The ingredient field of a report can be incomplete. The approved products below have all the ingredients of this page and one or more other ingredients.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| Panolog Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 012-258 |
| Panolog Cream | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 096-676 |
| Animax Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Fougera Pharmaceuticals, LLC | Dogs, Cats | NADA 140-847 |
| Derma 4 Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 140-879 |
| Derm-Otic Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 141-003 |
| Animax Cream | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Fougera Pharmaceuticals, LLC | Dogs, Cats | ANADA 200-330 |
| DERMA-VET Ointmentapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Med-Pharmex, Inc. | Dogs, Cats | NADA 140-810 |
| Derm-Otic Ointmentapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Biocraft Laboratories, Inc. | Dogs, Cats | NADA 140-889 |
| Derma-Vet Creamapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Med-Pharmex, Inc. | Dogs, Cats | ANADA 200-245 |
Other pages with one of these ingredients
A report names a drug by its set of active ingredients. Each set has its own page. The list is in order of name.
- Nystatin, all combinations
- Thiostrepton, all combinations
- Triamcinolone Acetonide, all combinations
- Neomycin Sulfate + Nystatin
- Neomycin Sulfate + Nystatin + Thiostrepton
- Neomycin Sulfate + Nystatin + Thiostrepton + Triamcinolone Acetonide
- Nystatin
- Nystatin + Thiostrepton + Triamcinolone
- Triamcinolone Acetonide
Next in the A to Z list
FDA pages for this drug
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Nystatin + Thiostrepton + Triamcinolone Acetonide: adverse event reports that FDA received. https://petdrugreports.com/drug/nystatin-thiostrepton-triamcinolone-acetonide/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. The site does not use the application number that a record has.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book lists no brand name for exactly these active ingredients.
- Do the reports show that the drug caused the signs?
No. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 16 reports in the 12 months to June 2026. It received 9 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 95 reports received from February 2013 to June 2026, 86.3% are about a safety issue only. 8.4% are about a lack of expected effectiveness, alone or with a safety issue. 5.3% are about a defect of the product or its package.